2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same
申请人:Rault Sylvain
公开号:US20060019995A1
公开(公告)日:2006-01-26
A compound selected from those of formula (I):
wherein:
R
1
represents hydrogen, aryl(C
1
-C
6
)alkyl, linear or branched (C
1
-C
6
)alkyl, linear or branched (C
1
-C
6
)acyl, linear or branched (C
1
-C
6
)alkoxycarbonyl, aryl(C
1
-C
6
)alkoxycarbonyl, or trifluoroacetyl,
R
2
represents hydrogen, linear or branched (C
1
-C
6
)alkyl,
X represents oxygen or NOR
3
,
R
3
represents hydrogen, linear or branched (C
1
-C
6
)alkyl optionally substituted by one or more identical or different groups selected from hydroxy, amino and linear or branched (C
1
-C
6
)alkoxy, Ar represents aryl or heteroaryl, its isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cognitive disorders and which possess antalgic properties.
从以下化学式(I)中选择的化合物:
其中:
R1代表氢、芳基(C1-C6)烷基、直链或支链(C1-C6)烷基、直链或支链(C1-C6)酰基、直链或支链(C1-C6)烷氧羰基、芳基(C1-C6)烷氧羰基或三氟乙酰基,
R2代表氢、直链或支链(C1-C6)烷基,
X代表氧或NOR3,
R3代表氢、直链或支链(C1-C6)烷基,可选择地被一个或多个相同或不同的羟基、氨基和直链或支链(C1-C6)烷氧基取代,Ar代表芳基或杂环芳基、其异构体以及与药学上可接受的酸或碱形成的加合盐,以及含有这些化合物的药物产品,用于治疗认知障碍并具有镇痛性能的。